Bank of America Corporation »

Avenue Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of Avenue Therapeutics shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in Avenue Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avenue Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avenue Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2024-06-30 $24 7 3.43

More positions owned by Bank of America Corporation

Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Rus 1000 Grw Etf (IWF)
JPMorgan Chase & Co. (JPM)

View all positions for Bank of America Corporation

Top funds holding Avenue Therapeutics

Armistice Capital
Tower Research Capital
Wells Fargo & Company
Royal Bank of Canada
Emfo
Bank of America Corporation
Jpmorgan Chase & Co

View all funds holding Avenue Therapeutics